We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+22.16%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$204M
AUM Growth
+$41.2M
(+25%)
Cap. Flow
+$34M
Cap. Flow
% of AUM
16.72%
Top 10 Holdings %
Top 10 Hldgs %
64.81%
Holding
152
New
50
Increased
18
Reduced
29
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MACOM Technology Solutions
MTSI
|
+$2.29M |
| 2 |
Coherent
COHR
|
+$2.02M |
| 3 |
MaxLinear
MXL
|
+$1.84M |
| 4 |
Everspin Technologies
MRAM
|
+$1.32M |
| 5 |
OBCI
Ocean Bio-Chem Inc
OBCI
|
+$1.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dropbox
DBX
|
+$1.91M |
| 2 |
EGIO
Edgio, Inc. Common Stock
EGIO
|
+$1.85M |
| 3 |
BFX
BowFlex Inc.
BFX
|
+$1.53M |
| 4 |
WIFI
Boingo Wireless, Inc.
WIFI
|
+$871K |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$771K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.48% |
| 2 | Healthcare | 6.98% |
| 3 | Consumer Discretionary | 2.55% |
| 4 | Consumer Staples | 1.24% |
| 5 | Real Estate | 1.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
PUT
Stryker
SYK
$125B
| – | – |
-16,600
| Closed | -$160K |
|
|
TRUE
127
DELISTED
TrueCar
TRUE
| – | – |
-67,050
| Closed | -$163K |
|
|
VIRX
128
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| – | – |
-10,352
| Closed | -$150K |
|
|
EGIO
129
DELISTED
Edgio, Inc. Common Stock
EGIO
| – | – |
-8,125
| Closed | -$1.85M |
|
|
BIOL
130
DELISTED
Biolase, Inc.
BIOL
| – | – |
-226
| Closed | -$212K |
|
|
CBAY
131
CALL
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-166,900
| Closed | -$4K |
|
|
QUMU
132
DELISTED
Qumu Corp.
QUMU
| – | – |
-46,896
| Closed | -$78K |
|
|
RESN
133
DELISTED
Resonant Inc.
RESN
| – | – |
-148,491
| Closed | -$219K |
|
|
WIFI
134
DELISTED
Boingo Wireless, Inc.
WIFI
| – | – |
-82,063
| Closed | -$871K |
|
|
MLNX
135
DELISTED
Mellanox Technologies, Ltd.
MLNX
| – | – |
-5,049
| Closed | -$613K |
|
|
LJPC
136
DELISTED
La Jolla Pharmaceutical Company
LJPC
| – | – |
-85,425
| Closed | -$358K |
|
|
CZR
137
PUT
DELISTED
Caesars Entertainment Corporation
CZR
| – | – |
-50,800
| Closed | -$64K |
|
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Worth Venture Partners held 152 positions worth $204M, up 25% from $162M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Worth Venture Partners deployed $34M of net new capital in Q2 2020, opening 50 new positions and adding to 18 existing holdings. Its largest new stake was MACOM Technology Solutions: 78,540 shares worth $2.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 8% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was BowFlex Inc., an estimated $1.53M trimmed.
- Worth Venture Partners's largest Q2 2020 buy was MACOM Technology Solutions: 78,540 shares worth $2.7M.
- Worth Venture Partners added most to scPharmaceuticals in Q2 2020, an estimated $280K increase.
- Worth Venture Partners's biggest Q2 2020 reduction was BowFlex Inc., cutting an estimated $1.53M.
- Worth Venture Partners fully exited Dropbox in Q2 2020, selling an estimated $1.91M.
- Worth Venture Partners's ten largest holdings make up 65% of its $204M portfolio in Q2 2020.
- Worth Venture Partners opened 50 new positions and closed 35 in Q2 2020.
- Worth Venture Partners's portfolio value rose 25% quarter-over-quarter to $204M.
Based on Worth Venture Partners's 13F filing for Q2 2020, filed 14 Aug 2020.